Home › Therapeutic areas › Oncology › Neuroendocrine Tumors

Neuroendocrine Tumors (3 companies)

Companies with an active program in Neuroendocrine Tumors.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
CRNX Crinetics Pharmaceuticals MetabolicOncology Rare 2 Approved — 6
EXEL Exelixis CardiovascularOncology 3 Approved $16.7B 23
CATX Perspective Therapeutics Oncology 1 Phase 1 $104M 5